Delivery Order SPE2DB22D3501-SPE2DB25FXC07
- Not listed
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $40,227 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $72,872.94 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor under its existing Indefinite Delivery Contract (IDC) vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $23,237.52 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, issued under a competitively awarded contract with no set-aside designation, will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,324.08 to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, issued without set-aside restrictions, represents a competitively awarded contract for pharmaceutical products and medical supplies supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $16,514.86 on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $152,556.74 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price, competitively awarded delivery order (Contract No. 4569202619) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The order is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,958.54 to AmerisourceBergen Drug Corp on August 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $166,128.90 to AmerisourceBergen Drug Corp on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the vendor's corporate office...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXC07Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Sodium Phenylacetate-Sodium Benzoate VL 50ML with a ceiling value of $16,121.40 and a firm fixed price structure. The order is due for completion by September 2, 2025, and represents a non-competitive, non-set-aside award executed under the company's existing contract vehicle. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies supporting military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement through the Defense Health Agency and other government healthcare entities, delivering a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 8/29/25 |